期刊文献+

替米考星β-环糊精聚合物微球的制备与表征 被引量:2

Preparation and Characterization of Tilmicosin β-Cyclodextrin Polymer Microspheres Inclusion Compound
下载PDF
导出
摘要 [目的]优化替米考星β-环糊精聚合物(β-CDP)微球的制备工艺。[方法]采用共沉淀法制备替米考星β-CDP微球,以包封率和产率的回归分析综合得分为指标,通过L9(34)正交试验设计对制备工艺进行优化;采用扫描电镜、激光粒度分布仪、红外光谱仪和综合热分析仪对替米考星β-CDP微球进行表征。[结果]最佳工艺条件为:β-CDP微球3 g、替米考星0.25 g、反应温度50℃、反应时间1 h、搅拌速度600 r/min;在最佳工艺条件下:产率为83.32%,包封率为67.61%。以优化工艺制备的载药微球形态良好,平均粒径为161.35μm;替米考星进入到β-CDP微球中的内部,且以无定形的状态分散在聚合物载体中,具有较好的热稳定性。[结论]替米考星β-CDP微球制备方法合理可行。 [Objective]To optimize the preparation technology of Tilmicosin β-cyclodextrin polymer micro-spheres inclusion compound.[Method]Tilmicosin β-cyclodextrin polymer microspheres inclusion compound was prepared by coprecipitation method.The preparation process was optimized through the L9(34) orthogonal experimental design,the regression analysis was based on the evaluation indicators of drug produce and encapsulation efficiency.Tilmicosin β-cyclodextrin polymer microspheres inclusion compound was characterized by SEM,laser particle analyzer,FT-IR spectroscopy and thermo gravimetric analysis(TGA).[Result]The best technological conditions were showed as following: the quantity of β-cyclodextrin polymer microspheres,Tilmicosin were 3 g,0.25 g respectively,the reacting temperature was 50 ℃,the reacting time was 3 h,stirring speed was 600 r/min.Under optimum conditions,the produce and drug encapsulation efficiency were 83.32% and 67.61% respectively.Through optimizing the preparation process,the loaded microspheres were endowed with good shape,and the average diameter of microparticle was 161.35 μm.Tilmicosin was dispersed with amorphous in microspheres,and it was ensured with good thermal stability.[Conclusion]The preparation method was reasonable and feasible.
出处 《安徽农业科学》 CAS 北大核心 2011年第2期1076-1078,共3页 Journal of Anhui Agricultural Sciences
基金 国家自然科学基金项目(50573046) 陕西省教育厅产业化培育项目(02JC05)
关键词 β-环糊精聚合物微球 替米考星 回归分析法 β-cyclodextrin polymer microspheres Tilmicosin Regression analysis
  • 相关文献

参考文献12

二级参考文献67

  • 1吕淑荣,何杰,杨磊,朗跃武.兽用抗菌新药替米考星的研究[J].动物科学与动物医学,2004,21(9):7-9. 被引量:11
  • 2侯冬枝,谢长生,黄寿吾.用注射法和复乳法制备低分子肝素脂质纳米粒[J].中国医院药学杂志,2004,24(11):672-674. 被引量:6
  • 3周绪正,张继瑜,李剑勇,李宏胜,李金善,徐忠赞.替米考星对猪传染性胸膜肺炎的治疗试验[J].动物医学进展,2005,26(6):84-88. 被引量:19
  • 4NERLAND E M, LEBLANC J M, FEDWICK J P, et al. Effects of oral administration of tilmieosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropn-eumoniae[J]. Am J Vet Res, 2005, 66(1):100-107.
  • 5BLACKALL P J, ASAKAWA T, GRAYDON R J, et al. In vitro-antibacterial properties of tilmieosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs [J]. Australian Veterinary Journal, 1995, 72: 1, 35-36.
  • 6The European agency for the evaluation of medicinal products. Tilmicosin Summary Report [R]. http:// www. emea. europa, eu/pdfs/vet/mrls/Tilmicosinl. pdf.
  • 7KART A, YAPAR K, KARAPEHLIVAN M, et al. The possible protective effect of L-carnitine on tilmicosin-induced cardiotoxicity in mice[J]. J Vet Med A Physiol Pathol Clin Med, 2007, 54(3) 144-146.
  • 8中国兽药典委员会.中华人民共和国药典[M].北京:化学工业出版社,2005.
  • 9PAPISOV M I, SAUELYEU V Y,SERGIENKO U B,et al. Magnetic drug targeting I in vivo kinetics of radio labelled magnetic drug carries [J ]. Int J Pharm, 1987,40:201-206.
  • 10JORDAN F T W, HORROCKS B K. The minimun inhibitory concentration of tilmicosin and tylosin for Mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks [J]. Avian Diseases, 1996, 40: 326-334.

共引文献72

同被引文献18

  • 1李宏胜,张继瑜,周旭正,李建勇,李金善,苗小楼,许忠赞,张占峰.替米考星对雏鸡增重及预防人工感染禽巴氏杆菌的效果观察[J].畜牧与兽医,2004,36(12):10-12. 被引量:10
  • 2Florian Priese, Bertram Wolf. Development of high drug loaded pellets by Design of Experiment and population balance model calculation[ J]. Powder Technology,2013, 241 : 149 - 157.
  • 3X F Wang, S L Zhang, L Y.Enhancement of antibacterial of tivity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo [ J ]. The Veterinary Journal, 2012, 1 (191): 115-120.
  • 4Fridrun Podczeck, John Michael Newton. Influence of the standing time of the extrudate and speed of rotation of the spheroniser plate on the properties of pellets produced by extrusion and spheronization [ J]. Advanced Powder Technolog. In Press, http://dx.doi.org/ 10.1016/j.apt. 2013.10.011.
  • 5P E Knight, F Podczeck, J M Newton. The theological properties of modified microcrystalline cellulose containing high levels of model drugs[J]. J Pharm Sci,2009, 98 : 2160 - 2169.
  • 6中国药典国家药典委员会.中华人民共和国药典2010年版第二部附录[S].
  • 7Pan Chen. Novel compaction techniques with pellet containing granules[J]. Eur J Pharm Biopharm,2010, 3(75) : 436-442.
  • 8李连闯,车文实.微丸成型工艺研究进展[J].安徽医科大学报,2013,48(4):453-455.
  • 9Akhgari A, Abbaspour M R, Moradkhanizadeh M. Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of PelletsPrepared by Extrusion-Spheronization for Possible Colonic Delivery of 5 - Amino Salicylic Acid [ J ]. Jundishapur journal of Natural Pharmaceutical Products,2013, 8(2) : 86-92.
  • 10赵永前,刘茂军,周勇歧,刘冬霞,邵国青.替米考星预混剂对人工诱发猪气喘病的疗效试验[J].畜牧与兽医,2007,39(11):60-62. 被引量:8

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部